Inactive Instrument

Avivagen Inc. Stock Toronto S.E.

VIV.H

CA05382F2026

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that enhances feed intake and supports immune function, thereby supporting general health and performance. The Companyâ€™s operations as one segment, products based on OxC-beta Technology. Its OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia.

Employees

Sector

Fishing & Farming

More about the company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	591K 507K 475K 435K 819K 56.44M 822K 5.62M 2.2M 28.44M 2.22M 2.17M 94.14M	P/E 2021	-3.05x	P/E 2022	-1.52x
Enterprise Value	6.39M 5.48M 5.13M 4.7M 8.85M 610M 8.88M 60.77M 23.76M 307M 23.98M 23.46M 1.02B	EV / Sales 2021	20.5x	EV / Sales 2022	17.7x
Free-Float	98.89%	Yield 2021 *	-	Yield 2022	-

24-04-24	Avivagen Makes Voluntary Assignment into Bankruptcy Under the BIA	NE
21-04-06	Avivagen Discusses Significant Purchase Orders for OxC-beta(TM) Livestock with The Stock Day Podcast	NE
20-07-23	Avivagen: The OxC-beta(TM) Technology Is A True Game Changer	NE
19-10-02	Avivagen Inc. CEO, Kym Anthony, Joins The Stock Day Podcast to Discuss Their Expansion Strategy	NE
18-05-01	Avivagen Announces its Attendance at the Bloom Burton & Co. Healthcare Investor Conference	GL

Manager	Title	Age	Since
G. Anthony CEO	Chief Executive Officer	70	2017-02-08
Ira Levy DFI	Director of Finance/CFO	-	-
Drew Basek IRC	Investor Relations Contact	-	2017-02-28

Director	Title	Age	Since
David Hankinson CHM	Chairman	-	2005-08-03
G. Anthony CHM	Chairman	70	2014-07-24
Paul Mesburis BRD	Director/Board Member	56	2016-04-04

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AVIVAGEN INC.	-.--%	-.--%	-	-	77
GUANGDONG HAID GROUP CO., LIMITED	-2.81%	-2.20%	-27.64%	-1.68%	10.91B
NEW HOPE LIUHE CO.,LTD.	+2.48%	-2.23%	-30.26%	-40.42%	4.66B
PT CHAROEN POKPHAND INDONESIA TBK	-0.33%	+0.33%	-32.59%	-41.36%	2.75B
AKTIESELSKABET SCHOUW & CO.	0.00%	+5.42%	+25.66%	+48.82%	2.67B
BEIJING DABEINONG TECHNOLOGY GROUP CO.,LTD.	+1.87%	-3.55%	-23.65%	-50.23%	2.08B
AVANTI FEEDS LIMITED	+0.66%	-1.87%	+31.87%	+101.89%	1.2B
FUJIAN AONONG BIOLOGICAL TECHNOLOGY GROUP INCORPORATION LIMITED	+2.46%	-3.96%	-22.81%	-67.67%	1.18B
WELLHOPE FOODS CO., LTD.	+1.74%	+0.78%	-27.34%	-27.67%	829M
GUANGDONG YUEHAI FEEDS GROUP CO.,LTD.	+1.57%	-3.97%	+0.13%	-14.65%	808M
Average	+0.76%	+0.64%	-11.85%	-10.33%	3.01B
Weighted average by Cap.	-0.36%	+0.52%	-19.35%	-10.60%

Avivagen Inc. Stock Toronto S.E.

Stocks

VIV.H

CA05382F2026

Fishing & Farming

Valuation : Avivagen Inc.

Press Releases : Avivagen Inc.

Managers and Directors : Avivagen Inc.

Animal Feed

Financials

Company Profile

	2021	2022
Net sales	1.3M 1.11M 1.04M 954K 1.8M 124M 1.8M 12.33M 4.82M 62.38M 4.87M 4.76M 206M	939K 806K 755K 691K 1.3M 89.7M 1.31M 8.94M 3.49M 45.21M 3.53M 3.45M 150M
Net income	-6.39M -5.49M -5.14M -4.71M -8.86M -611M -8.89M -60.85M -23.79M -308M -24.01M -23.49M -1.02B	-6.07M -5.21M -4.88M -4.46M -8.41M -579M -8.43M -57.73M -22.57M -292M -22.78M -22.28M -966M
Net Debt	5.4M 4.63M 4.34M 3.97M 7.48M 516M 7.51M 51.37M 20.08M 260M 20.27M 19.83M 860M	5.8M 4.97M 4.66M 4.26M 8.03M 553M 8.06M 55.15M 21.56M 279M 21.76M 21.29M 923M